US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)—CVS Health Inc’s (NYSE:CVS) Caremark, Cigna Corp’s (NYSE:CI) Express Scripts,
FTC Sues CVS, Cigna, UnitedHealth over insulin prices
The agency said it filed a complaint in its administrative court alleging that CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in exchange for keeping lower-cost insulin off their lists of approved ...
Express Scripts by Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today issued the following statement in response to the Federal Trade Commission's reckless insulin action: ...
Cigna Group’s pharmacy benefit manager Express Scripts on Tuesday sued the U.S. Federal Trade Commission, alleging that the ...
The FTC report said the companies responsible for controlling spending on drugs were sometimes steering patients toward more ...
Express Scripts parent company Cigna alleges the Federal Trade Commission ignored more than 3 million pages of documents the ...
Express Scripts has filed suit against the Federal Trade Commission, demanding that the agency retract a damning report on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback